Wage-subsidised employment as a result of permanently reduced work capacity in a nationwide cohort of patients diagnosed with haematological malignancies

Acta Oncologica
Trine A HorsboelAnnette de Thurah

Abstract

Patients with haematological malignancies have a poorer labour market prognosis than the general population. We have previously found that they have low rates of return to work, and a higher risk of being granted disability pension, than individuals without a history of these diseases. The aim of this study was to further investigate the labour market prognosis for these patients, by comparing the risk of being granted wage-subsidised (WS) employment as a result of permanently reduced work capacity among patients diagnosed with haematological malignancies to a reference cohort, and to determine if relative risks differ between subtypes of haematological malignancies. We combined data from national registers on Danish patients diagnosed with haematological malignancies between 2000 and 2007 and a reference cohort without a history of these diseases. A total of 3194 patients and 28 627 reference individuals were followed until they were granted WS employment, disability pension, anticipatory pension, old age pension, emigration, death or until 26 February 2012, whichever came first. A total of 310 (10%) patients and 795 (3%) reference individuals had their work capacity permanently reduced to an extent that they were granted WS e...Continue Reading

References

Feb 9, 2005·Cancer·Pamela Farley ShortKaan Tunceli
Mar 8, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jae-Hyun ParkSang-Yi Lee
Mar 20, 2008·British Journal of Cancer·A G E M de BoerF J H van Dijk
Jun 4, 2008·Scandinavian Journal of Public Health·Kathrine CarlsenChristoffer Johansen
Sep 17, 2008·Journal of Cancer Survivorship : Research and Practice·Astri SyseØystein Kravdal
Nov 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michele BaccaraniUNKNOWN European LeukemiaNet
Jan 15, 2011·Acta Oncologica·Susanne Oksbjerg DaltonChristoffer Johansen
Aug 4, 2011·Scandinavian Journal of Public Health·Carsten Bøcker Pedersen
Jun 19, 2012·Journal of Cancer Survivorship : Research and Practice·Steffen TorpAlv A Dahl
Sep 26, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Karen L SyrjalaStephanie J Lee
Nov 28, 2012·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Kristin M PhillipsPaul B Jacobsen
Jan 17, 2013·Acta Oncologica·Susanne O Dalton, Christoffer Johansen
Aug 21, 2013·Journal of Cancer Survivorship : Research and Practice·Trine Allerslev HorsboelAnnette de Thurah
Mar 8, 2014·International Journal of Cancer. Journal International Du Cancer·Lina Jansen, Hermann Brenner

❮ Previous
Next ❯

Citations

Apr 25, 2015·Acta Oncologica·Christoffer Johansen, Susanne Oksbjerg Dalton
Mar 11, 2015·Acta Oncologica·Christoffer Johansen, Susanne Oksbjerg Dalton
Nov 18, 2018·Annals of Hematology·Sandra De BarrosFabrice Herin
Jun 22, 2021·European Journal of Cancer Care·Christine BenninkSaskia F A Duijts

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.